Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Aurinia Pharmaceuticals Q3 Earnings

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
byBenzinga Insights
November 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Aurinia Pharmaceuticals beat estimated earnings by 64.71%, reporting an EPS of $-0.06 versus an estimate of $-0.17.

Revenue was up $41.11 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 1.76% drop in the share price the next day.

 

To track all earnings releases for Aurinia Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Gamida Cell

By Benzinga Insights
August 12, 11:09 AM
  Gamida Cell (NASDAQ:GMDA) is set to give its latest quarterly earnings report on Monday, 2022-08-15. Here's what investors need to know before the announcement. Analysts estimate that Gamida Cell will report an earnings per share (EPS) of $-0.29.

GMDA